Abstract

Non-operative management of patients with abdominal aortic aneurysm (AAA) is required for several different reasons. Since these patients have an increased risk of cardiovascular death therapy to reduce cardiovascular events is essential. Treatment is in line with the medical management of coronary artery disease including smoking cessation, statins and anti-platelet therapy. Some of these therapies also will slow aneurysm growth, which is a target in the management of patients with small AAA. As yet there is no targeted therapy that reduces aneurysm growth, but there is active research in this area. Medical management also is required to reduce peri-operative risks, stabilise endovascular aneurysm repair and minimise the risk of rupture in those with large AAA unfit for aneurysm repair.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call